DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,053 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $233,360 | +8.8% | 934 | +8.7% | 0.01% | 0.0% |
Q1 2024 | $214,509 | -21.2% | 859 | -27.0% | 0.01% | -28.6% |
Q4 2023 | $272,056 | -8.6% | 1,176 | -2.0% | 0.01% | -12.5% |
Q3 2023 | $297,720 | +2.6% | 1,200 | -0.7% | 0.01% | +14.3% |
Q2 2023 | $290,160 | +4.5% | 1,209 | +9.7% | 0.01% | -12.5% |
Q1 2023 | $277,748 | -21.7% | 1,102 | -17.5% | 0.01% | -27.3% |
Q4 2022 | $354,601 | +343.3% | 1,336 | +332.4% | 0.01% | +450.0% |
Q3 2022 | $80,000 | +9.6% | 309 | +7.3% | 0.00% | 0.0% |
Q2 2022 | $73,000 | +1116.7% | 288 | +1340.0% | 0.00% | – |
Q1 2022 | $6,000 | -14.3% | 20 | 0.0% | 0.00% | – |
Q4 2021 | $7,000 | +16.7% | 20 | 0.0% | 0.00% | – |
Q3 2021 | $6,000 | +200.0% | 20 | +150.0% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 8 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 8 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 8 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | +100.0% | 8 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | -66.7% | 8 | -68.0% | 0.00% | – |
Q1 2020 | $3,000 | +200.0% | 25 | +212.5% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 8 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | -90.9% | 8 | -92.2% | 0.00% | -100.0% |
Q4 2018 | $11,000 | +1000.0% | 103 | +930.0% | 0.00% | – |
Q1 2018 | $1,000 | – | 10 | +900.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 1 | -98.2% | 0.00% | – |
Q2 2017 | $5,000 | – | 55 | +5400.0% | 0.00% | – |
Q3 2015 | $0 | -100.0% | 1 | -95.0% | 0.00% | -100.0% |
Q4 2013 | $2,000 | – | 20 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |